2920
Q. Wang, C. Chen / Tetrahedron Letters 49 (2008) 2916–2921
14. Butts, S. B.; Strauss, S. H.; Holt, E. M.; Stimson, R. E.; Alcock, N.
W.; Shriver, D. F. J. Am. Chem. Soc. 1980, 102, 5093–5100.
15. Wax, M. J.; Bergman, R. G. J. Am. Chem. Soc. 1981, 103, 7028–
7030.
16. Lee, K.-s.; Brown, M. K.; Hird, A. W.; Hoveyda, A. H. J. Am. Chem.
Soc. 2006, 128, 7182–7184.
1H), 5.56 (m, 1H), 5.41 (m, 1H), 2.27–2.43 (m, 4H), 1.93 (s, 3H), 1.70–
1.58 (m, 4H); 13C NMR (75 MHz, CDCl3) d 200.0, 143.7, 141.8,
138.1, 122.3, 25.9, 23.7, 22.0, 21.6, 19.2; MS(EI) 150 [M]+.
Table 2, entry 5: Rf = 0.43 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2930, 2855, 1663, 1449, 1196; 1H NMR (400 MHz, CDCl3) d 6.89 (m,
1H), 2.97 (dddd, J = 11.4, 11.4, 3.2, 3.2 Hz, 1H), 2.25–2.21 (m, 4H),
1.80–1.58 (m, 9H), 1.43–1.17 (m, 5H); 13C NMR (75 MHz, CDCl3) d
205.1, 138.9, 138.1, 44.1, 29.8 (2C), 26.1, 25.9 (2C), 25.7, 23.3, 22.0,
21.6; MS(EI) 192 [M]+.
17. General procedure: A round-bottom flask equipped with magnetic
stirbar was charged with ZnBr2 (1.48 g, 6.6 mmol) or ZnCl2 (0.90 g,
6.6 mmol) and flame-dried under vacuum. Anhydrous THF (12 mL)
was then introduced followed by a THF or Et2O solution of the
Grignard or organolithium reagent (12 mmol) at room temperature.
After stirring overnight, the solvents were removed under vacuum
(0.1 mmHg) or by distillation under ambient pressure at 100 °C. The
diorganozinc reagents and MgBr2 generated in situ were then
dissolved in DMSO (40 mL), leaving 25% of MgBr2 undissolved.
In a separate flask, carbon monoxide was bubbled through a solution
of enol triflate (1.0 mmol) in degassed DMSO (1 mL) for 2 min before
a solution of diorganozinc reagent (0.165 M in DMSO, 1.3 mmol,
8 mL) was added via syringe pump (25 mL/h) at 50 °C with
continuous carbon monoxide bubbling (54 mL/min). The amount of
dissolved MgBr2 was calculated to be 1.8 equiv (1.3 ꢁ 12/
6.6 ꢁ 0.75 = 1.8). After 30 sec, a solution of NiCl2–1 (0.2 M in
THF, 0.02 mmol, 0.1 mL) was introduced. The reaction mixture
turned deep red, which faded to pale yellow upon the completion of
the reaction. CAUTION: The catalyst deactivation leads to the
generation of Ni(CO)4, which is toxic and volatile. It may be released
from the reaction vessel through carbon monoxide bubbling. This
reaction should be performed in a well-ventilated fume hood. After
cooling to room temperature, the solution was passed through a short
pad of silica gel to remove DMSO and inorganic salts. The silica gel
was washed with 10% Et2O–pentane solution. The filtrate was
concentrated and purified by flash column chromatography.
5-Methylcyclopent-1-enyltrifluoromethanesulfonate: Rf = 0.35 (pen-
tane); 1H NMR (400 MHz, CDCl3) d 5.61 (m, 1H), 2.90 (m, 1H),
Table 2, entry 6: Rf = 0.30 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2930, 1667, 1229; 1H NMR (400 MHz, CDCl3) d 6.89 (m, 1H), 2.61 (t,
J = 7.4 Hz, 2H), 2.24 (m, 4H), 1.62–1.55 (m, 6H), 1.29 (m, 6H), 0.89
(t, J = 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 212.2, 139.5, 139.2,
37.0, 31.7, 29.1, 26.0, 24.9, 23.1, 22.5, 22.0, 21.6, 14.1; MS(EI) 194
[M]+.
Table 3, entry 1: Rf = 0.39 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2955, 1643, 1608, 1355, 734; 1H NMR (400 MHz, CDCl3) d 7.33–7.17
(m, 4H), 6.37 (m, 1H), 2.72 (m, 2H), 2.57 (m, 2H), 2.32 (s, 3H), 2.02
(m, 2H); 13C NMR (75 MHz, CDCl3) d 196.7, 149.1, 146.3, 139.8,
135.7, 130.8, 129.6, 127.6, 124.9, 34.2, 30.6, 23.0, 19.6; MS(EI) 186
[M]+.
Table 3, entry 2: Rf = 0.26 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2956, 1644, 1585, 1439, 1355, 1270, 779, 736; 1H NMR (400 MHz,
CDCl3) d 7.50 (m, 1H), 7.43–7.38 (m, 2H), 7.21 (dt, J = 8.3, 7.9,
2.2 Hz, 1H), 6.57 (m, 1H), 2.74 (m, 2H), 2.63 (m, 2H), 2.01 (m, 2H);
13C NMR (75 MHz, CDCl3) d 192.6, 162.4 (d, J = 246 Hz), 147.6,
144.3, 141.0 (d, J = 6.5 Hz), 129.8 (d, J = 7.8 Hz), 124.5 (d,
J = 3.0 Hz), 118.7 (d, J = 21.3 Hz), 115.6 (d, J = 22.5 Hz), 34.4,
31.7, 22.7; MS(EI) 190 [M]+.
Table 3, entry 3:Rf = 0.34 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2956, 1646, 1585, 1439, 1349, 1269, 748; 1H NMR (400 MHz, CDCl3)
d 7.52 (m, 1H), 7.44–7.37 (m, 2H), 7.22 (dt, J = 8.2, 8.2, 2.5 Hz, 1H),
6.46 (m, 1H), 3.26 (m, 1H), 2.65 (m, 1H), 2.47 (m, 1H), 2.24 (m, 1H),
1.59 (m, 1H), 1.17 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) d
192.8, 162.4 (d, J = 247.5 Hz), 148.5, 146.5, 141.2 (d, J = 6.2 Hz),
129.8 (d, J = 7.8 Hz), 124.6 (d, J = 3.0 Hz), 118.7 (d, J = 21.4 Hz),
115.7 (d, J = 22.4 Hz), 39.5, 32.5, 31.9, 19.4. MS(EI) 204 [M]+.
2.36 (m, 2H), 2.24 (m, 1H), 1.56 (m, 1H), 1.14 (d, J = 6.8 Hz, 3H); 13
C
NMR (100 MHz, CDCl3) d 153.2, 118.9 (q, J = 318.6 Hz), 116.1,
37.7, 29.9, 26.4, 18.0; MS(EI) 230 [M]+.
(5E)-5-Iodo-dec-5-ene Rf = 0.67 (pentane); 1H NMR (400 MHz,
CDCl3) d 6.17 (t, J = 7.6 Hz, 1H), 2.35 (t, J = 7.3 Hz, 2H), 2.04 (m,
2H), 1.43 (m, 2H), 1.35 (m, 6H), 0.91 (m, 6H); 13C NMR (125 MHz,
CDCl3) d 141.4, 103.5, 38.2, 31.4, 31.3, 30.6, 22.2, 21.5, 14.0, 13.9;
MS(EI) 266 [M]+.
Table 3, entry 4: Rf = 0.35 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2954, 2930, 2865, 1666, 1376; 1H NMR (400 MHz, CDCl3) d 6.66 (m,
1H), 3.04 (m, 1H), 2.62 (t, J = 7.5 Hz, 2H), 2.42 (m, 1H), 2.47 (m,
1H), 2.17 (m, 1H), 1.61–1.49 (m, 3H), 1.29 (m, 5H), 1.07 (d,
J = 6.9 Hz, 3H), 0.88 (t, J = 6.3 Hz, 3H); 13C NMR (75 MHz,
CDCl3) d 199.5, 150.0, 142.5, 39.3, 38.2, 32.0, 31.8, 31.6, 29.0, 24.8,
22.5, 19.7, 14.0; MS(EI) 194 [M]+.
Table 1, entry 11: Rf = 0.39 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
1
2933, 1644, 1276, 1255, 702; H NMR (400 MHz, CDCl3) d 7.63 (m,
2H), 7.51 (m, 1H), 7.42 (m, 2H), 6.58 (m, 1H), 2.44 (m, 2H), 2.29 (m,
2H), 1.77 (m, 4H); 13C NMR (75 MHz, CDCl3) d 198.3, 144.1, 138.7,
131.2, 129.1, 128.0, 26.1, 23.9, 22.0, 21.6; MS(EI) 186 [M]+.
Table 3, entry 5: Rf = 0.29 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2928, 2867, 1649, 1453, 1243, 911, 740; 1H NMR (400 MHz, CDCl3) d
7.56 (dd, J = 7.7, 1.1 Hz, 1H), 7.35 (dt, J = 7.5, 7.5, 1.4 Hz, 1H), 7.23
(m, 2H), 2.66 (m, 2H), 2.55 (s, 3H), 2.07 (m, 2H), 1.74 (m, 2H), 1.65 (m,
1H), 1.55 (s, 3H), 1.46 (m, 1H), 0.94 (d, J = 7.0 Hz, 3H); 13C NMR
(75 MHz, CDCl3) d 203.2, 138.9, 138.5, 138.4, 137.6, 131.8, 131.1,
130.4, 125.6, 32.3, 30.8, 30.4, 21.3, 20.9, 19.9, 19.4; MS(EI) 228 [M]+.
Table 2, entry 1: Rf = 0.39 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2928, 1649, 1252, 730; 1H NMR (400 MHz, CDCl3) d 7.29 (m, 2H),
7.20 (m, 1H), 6.49 (m, 1H), 2.40 (m, 1H), 2.44 (m, 2H), 2.26 (s, 3H),
2.24 (m, 2H), 1.75 (m, 4H); 13C NMR (75 MHz, CDCl3) d 200.3,
146.4, 140.0, 139.7, 135.5, 130.5, 129.1, 127.4, 124.9, 26.3, 22.9, 21.9,
21.6, 19.5; MS(EI) 200 [M]+.
Table 3, entry 6: Rf = 0.11 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2920, 2849, 1638, 1600, 1251, 1170, 754; 1H NMR (400 MHz, CDCl3)
d 7.68 (m, 2H), 6.91 (m, 2H), 6.59 (t, J = 6.8 Hz, 1H), 3.85 (s, 3H), 2.59
(m, 2H), 2.33 (m, 2H), 1.83 (m, 2H), 1.59 (m, 4H); 13C NMR (75 MHz,
CDCl3) d 197.8, 162.4, 145.7, 145.2, 131.8, 130.9, 113.2, 55.4, 32.3,
29.2, 28.5, 26.6, 26.1; MS(EI) 230 [M]+.
Table 2, entry 2: Rf = 0.39 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2935, 1649, 1584, 1436, 1260, 792, 745; 1H NMR (400 MHz, CDCl3) d
7.40 (m, 2H), 7.32 (m, 1H), 7.18 (m, 1H), 6.61 (m, 1H), 2.40 (m, 2H),
2.29 (m, 2H), 1.76–1.64 (m, 4H); 13C NMR (75 MHz, CDCl3) d 196.6,
162.3 (d, J = 247.5 Hz), 144.8, 140.8 (d, J = 6.3 Hz), 138.5, 129.7 (d,
J = 7.8 Hz), 124.8 (d, J = 3.0 Hz), 118.1 (d, J = 21.3 Hz), 116.0 (d,
J = 22.4 Hz), 26.2, 23.8, 21.9, 21.5; MS(EI) 204 [M]+.
Table 3, entry 7: Rf = 0.43 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
1
2922, 2851, 1642, 1448, 1129; H NMR (400 MHz, CDCl3) d 6.77 (t,
J = 6.8 Hz, 1H), 5.56 (m, 1H), 5.42 (m, 1H), 2.46 (m, 2H), 2.32 (m,
2H), 1.93 (s, 3H), 1.78 (m, 2H), 1.57–1.49 (m, 4H); 13C NMR
(75 MHz, CDCl3) d 200.4, 146.0, 144.7, 143.9, 122.8, 32.3, 29.1, 27.5,
26.4, 26.0, 19.2; MS(EI) 164 [M]+.
Table 2, entry 3: Rf = 0.07 (10% Et2O–pentane); FTIR (neat, cmꢂ1
)
2933, 1638, 1600, 1251, 1170, 839, 756; 1H NMR (400 MHz, CDCl3) d
7.70 (d, J = 8.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 2H), 6.49 (m, 1H), 3.86
(s, 3H), 2.40 (m, 2H), 2.26 (m, 2H), 1.76–1.66 (m, 4H); 13C NMR
(75 MHz, CDCl3) d 197.2, 162.4, 141.6, 138.6, 131.6, 131.0, 113.3,
55.4, 25.9, 24.3, 22.1, 21.7; MS(EI) 216 [M]+.
(Z)-4-Butyl-2-methylnona-1,4-dien-3-one (12): Rf = 0.47 (10% Et2O–
pentane); FTIR (neat, cmꢂ1) 2957, 2927, 1643, 1100; 1H NMR
(400 MHz, CDCl3) d 6.27 (t, J = 7.4 Hz, 1H), 5.59 (m, 1H), 5.44 (m,
1H), 2.35 (m, 2H), 2.24 (m, 2H), 1.96 (s, 3H), 1.55–1.29 (m, 8H), 0.94–
0.88 (m, 6H); 13C NMR (75 MHz, CDCl3) d 200.8, 144.5, 143.7, 140.6,
Table 2, entry 4: Rf = 0.27 (10% Et2O–pentane); FTIR (neat, cmꢂ1
2931, 1641, 1168, 926, 779; 1H NMR (400 MHz, CDCl3) d 6.68 (m,
)